GO
Loading...

Enter multiple symbols separated by commas

Stocks St. Jude Medical Inc

More

  • US STOCKS-Apple, other tech stocks weigh on Wall St Wednesday, 22 Jul 2015 | 11:27 AM ET

    *Microsoft, Yahoo lower after results disappoint. *Thoratec jumps after $3.4 bln St. Microsoft fell as much as 4 percent to $45.35 after reporting its biggest quarterly loss, as the company wrote down its Nokia phone business and demand fell for its Windows operating system.

  • *Offers $63.50/ share for Thoratec. *Thoratec's shares rise 10 pct; St. July 22- St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion, giving it more devices for patients with the highest risk of heart failure.

  • BUZZ-Thoratec Corp: St. Jude Medical to buy for $3.4 bln Wednesday, 22 Jul 2015 | 8:00 AM ET

    JUDE MEDICAL TO BUY FOR $3.4 BLN@** Heart device maker's shares up 9.3 pct at $62.94. **Bigger rival St. Jude Medical Inc agrees to buy Thoratec for $3.4 bln to expand heart failure device portfolio. **Thoratec shares closed up 18 pct Tuesday after Bloomberg report on St.

  • July 22- St. Jude Medical Inc agreed to buy smaller rival Thoratec Corp for about $3.4 billion to expand its portfolio of heart failure devices. Jude said on Wednesday it would offer $63.50 per Thoratec share, which represents a premium of about 10 percent to the stock's Tuesday close. Thoratec's shares closed up 18 percent on Tuesday after Bloomberg reported...

  • St. Jude Medical adds more heart devices in $3.4B buy Wednesday, 22 Jul 2015 | 7:35 AM ET

    NEW YORK— St. Jude Medical will spend $3.4 billion in cash to acquire Thoratec, further bulking up its array of devices that are used to treat heart conditions. Thoratec's key product is an implantable device that helps patients' hearts pump more blood. Thoratec Corp. will be required to pay a termination fee of about $30 million if it backs out of the deal during the...

  • St. Jude tops Street 2Q forecasts Wednesday, 22 Jul 2015 | 7:18 AM ET

    ST. PAUL, Minn.— St. Jude Medical Inc. on Wednesday reported second-quarter earnings of $290 million. The average estimate of 19 analysts surveyed by Zacks Investment Research was for earnings of 99 cents per share. Nineteen analysts surveyed by Zacks expected $1.39 billion.

  • Heart device maker St. Jude to buy Thoratec for $3.4 bln Wednesday, 22 Jul 2015 | 7:10 AM ET

    July 22- Heart device maker St. Jude Medical Inc said it would buy smaller rival Thoratec Corp for $3.4 billion. Jude said it would offer $63.50 per Thoratec share, which represents a premium of about 10 percent to the stock's Tuesday close. Thoratec shares closed up 18 percent on Tuesday after Bloomberg reported that St.

  • July 21- Heart device maker St. Jude Medical Inc is in talks to buy smaller rival Thoratec Corp, Bloomberg reported, citing sources familiar with the matter. No final deal has been agreed and Thoratec could also opt to seek a different buyer, the report said. Pleasanton, California- based Thoratec's stock rose 27 percent to a record high of $62.05 on the Nasdaq on...

  • *IBM down after revenue falls for 13th straight quarter. *Apple, Microsoft, Yahoo to report results after market. July 21- U.S. stocks fell in early afternoon trading on Tuesday as weak revenue at IBM and United Technologies weighed on the Dow and investors awaited results from tech giants including Apple and Microsoft.

  • July 21- Heart device maker St. Jude Medical Inc is in talks to buy smaller rival Thoratec Corp, Bloomberg reported, citing sources familiar with the matter. While the two companies are in discussions, no final deal has been agreed, and Thoratec could also opt to seek a different buyer, the report said. Pleasanton, California- based Thoratec's stock rose 27 percent to a...

  • June 12- The U.S. Food and Drug Administration said it approved a brain implant from St. Jude Medical Inc that helps reduce symptoms of Parkinson's disease and essential tremor, a neurological disorder that causes rhythmic shaking. The device can be used when medication alone may not provide adequate relief from symptoms such as walking difficulties, balance...

  • *Syngenta rises on BASF bid interest. LONDON, June 4- European shares pared most of their daily losses on Thursday as a rally in the euro and bond yields paused, helped by some better-than-expected U.S. economic data. The European Central Bank's insistence on Wednesday that there was no need to adjust monetary policy in the face of volatility had caused a spike in...

  • *Syngenta rises on BASF bid interest. LONDON, June 4- Top European shares fell to their lowest level in almost a month on Thursday as a jump in the euro and a spike in bond yields cast a shadow on borrowing costs and export prospects for companies in the region. The European Central Bank's insistence on Wednesday that there was no need to adjust monetary policy in the...

  • Earnings next test for stocks after market wipeout Monday, 20 Apr 2015 | 5:52 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Stocks could chop around and rack up more losses in the week ahead, with the next wave of corporate earnings reports.

  • Earnings next test for stocks after market wipeout Friday, 17 Apr 2015 | 4:29 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Stocks could chop around and rack up more losses in the week ahead, with the next wave of corporate earnings reports.

  • LONDON, March 5- British fund manager Schroders Plc reported a better than expected jump in profits on Thursday, as net inflows more than tripled and assets under management rose to a record level, sending its share price to a fresh life-time high. Schroders said it took in a net 24.8 billion pounds of new investments over the year and added 12.3 billion pounds from...

  • NEW YORK/ BOSTON, Feb 11- Security experts are warning healthcare and insurance companies that 2015 will be the "Year of the Healthcare Hack," as cybercriminals are increasingly attracted to troves of personal information held by U.S. insurers and hospitals that command high prices on the underground market. "People feel that this will be the year of medical...

  • St. Jude outlook lower on foreign exchange impact Wednesday, 28 Jan 2015 | 10:52 AM ET
    Illustration of St. Jude Medical's LibraXP device

    St. Jude Medical on Wednesday predicted that foreign-exchange headwinds would pressure its sales and dampen its outlook for the coming year.

  • Apple gives Wall Street relief, Fed, Facebook loom Wednesday, 28 Jan 2015 | 5:24 AM ET
    A trader works on the floor of the NYSE as Fed Chair Janet Yellen speaks on television during a June news conference.

    US stock index futures signaled a slightly higher open, with European stocks boosted early in the day after Apple smashed analyst expectations.

  • What's boosting healthiest sector in S&P this year Monday, 27 Oct 2014 | 1:43 PM ET

    Health care has been on a tear in 2014, and there is still room for upside. Wall Street analysts are focusing on the following four trends.